Revalor Xr is a drug owned by INTERVET, INC. It is protected by 1 US drug patent filed in 2019. All patents have expired. Details of Revalor Xr’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US39592 | Active | |
Exclusivity Information
Revalor Xr holds 1 exclusivity out of which 1 has expired. Details of Revalor Xr's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Feb 13, 2020 |
About Revalor Xr
Revalor Xr is a drug
owned by INTERVET, INC.
Revalor Xr uses
Estradiol, Trenbolone Acetate as the active
ingredients.
Active Ingredient:
Revalor Xr uses
Estradiol,
Trenbolone Acetate
as the active ingredients.
Check out other Drugs and Companies using
Estradiol, Trenbolone Acetate ingredient.